About the Authors
- Avinash Gill
-
Current address: Bio-Architecture Lab, Berkeley, California, United States of America
Affiliation Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire, United States of America
- Thomas C. Scanlon
-
Affiliation Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire, United States of America
- Daniel C. Osipovitch
-
Affiliation Program in Experimental and Molecular Medicine, Dartmouth College, Hanover, New Hampshire, United States of America
- Dean R. Madden
-
Affiliations Department of Biochemistry, Dartmouth Medical School, Dartmouth College, Hanover, New Hampshire, United States of America, Program in Molecular and Cellular Biology, Dartmouth College, Hanover, New Hampshire, United States of America
- Karl E. Griswold
-
* E-mail: Karl.E.Griswold@Dartmouth.edu
Affiliations Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire, United States of America, Program in Molecular and Cellular Biology, Dartmouth College, Hanover, New Hampshire, United States of America, Department of Biological Sciences, Dartmouth College, Hanover, New Hampshire, United States of America
Competing Interests
KEG and TCS have filed a patent application on the therapeutic applications of the engineered human lysozyme. PCT/US10/21363 entitled “Therepeutic Charge Engineered Variants of Lysozyme and Methods for Using the Same to Treat Infections” was filed on January 16, 2010. This patent application does not alter the authors' willingness to adhere to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: AG TCS KEG. Performed the experiments: AG DCO KEG. Analyzed the data: AG DCO KEG. Contributed reagents/materials/analysis tools: TCS DRM. Wrote the paper: AG DRM KEG.